Larvol Delta - Anokion-Announces-Positive-Symptom-Data-from-its-Phase-2-Trial-Evaluating-KAN101-for-the-Treatment-of-Celiac-Disease

KAN-101 - Anokion

https://www.businesswire.com/news/home/20250108066537/en/Anokion-Announces-Positive-Symptom-Data-from-its-Phase-2-Trial-Evaluating-KAN-101-for-the-Treatment-of-Celiac-Disease

Jan 8, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next